These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2588105)

  • 41. Hypercalcemia after renal transplantation.
    Schwartz GH; David DS; Riggio RR; Saville PD; Whitsell JC; Stenzel KH; Rubin AL
    Am J Med; 1970 Jul; 49(1):42-51. PubMed ID: 4914475
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of phosphate on the parathyroid gland: direct and indirect?
    Rodriguez M; Almaden Y; Hernandez A; Torres A
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):321-8. PubMed ID: 8823529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mechanism for skeletal resistance in uremia.
    Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
    Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats.
    Denda M; Finch J; Brown AJ; Nishii Y; Kubodera N; Slatopolsky E
    Kidney Int; 1996 Jul; 50(1):34-9. PubMed ID: 8807569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects in the rat of varying intakes of dietary calcium, phosphorus, and hydrogen ion on hyperparathyroidism due to chronic renal failure.
    Kaye M
    J Clin Invest; 1974 Jan; 53(1):256-69. PubMed ID: 4808640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parathyroid hormone secretion in primary hyperparathyroidism.
    Bouillon R; de Moor P
    J Clin Endocrinol Metab; 1977 Aug; 45(2):261-9. PubMed ID: 407239
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients.
    Morachiello P; Landini S; Fracasso A; Righetto F; Scanferla F; Toffoletto P; Genchi R; Bazzato G
    Blood Purif; 1991; 9(3):148-52. PubMed ID: 1801857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia.
    Szabo A; Merke J; Beier E; Mall G; Ritz E
    Kidney Int; 1989 Apr; 35(4):1049-56. PubMed ID: 2709685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.
    Zhang Q; Qiu J; Li H; Lu Y; Wang X; Yang J; Wang S; Zhang L; Gu Y; Hao CM; Chen J
    J Am Soc Nephrol; 2011 Apr; 22(4):664-72. PubMed ID: 21335517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum osteocalcin levels in primary hyperparathyroidism.
    Pietschmann P; Niederle B; Anvari A; Woloszczuk W
    Klin Wochenschr; 1991 May; 69(8):351-3. PubMed ID: 1886398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary and secondary uraemic hyperparathyroidism: from initial clinical observations to recent findings.
    Drüeke TB
    Nephrol Dial Transplant; 1998 Jun; 13(6):1384-7. PubMed ID: 9641165
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of severe uremic hyperparathyroidism using a method for percutaneous injection of the parathyroid glands with ethanol].
    Niemczyk S; Elwerowski M; Matuszkiewicz-Rowińska J; Sitkowska-Kurzec Z; Sokalski A; Dziecioł-Jastrzebska M; Gomółka M; Kulicki P; Karolak B; Przedlacki J
    Pol Arch Med Wewn; 1999 Feb; 101(2):139-43. PubMed ID: 10723228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
    Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
    Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol.
    Lopez-Hilker S; Dusso AS; Rapp NS; Martin KJ; Slatopolsky E
    Am J Physiol; 1990 Sep; 259(3 Pt 2):F432-7. PubMed ID: 2396669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypotensive action of parathyroid hormone in hypoparathyroid and hyperparathyroid rats.
    Baksi SN
    Hypertension; 1988 Jun; 11(6 Pt 1):509-13. PubMed ID: 3384466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.
    Hannula PM; Pörsti IH; Saha HH; Kalliovalkama J; Jolma PM; Kööbi P; Olander RM; Antonen JA
    Clin Nephrol; 2004 Jun; 61(6):406-12. PubMed ID: 15224804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early stage of urolithiasis formation in experimental hyperparathyroidism.
    Yamaguchi S; Yachiku S; Okuyama M; Tokumitsu M; Kaneko S; Tsurukawa H
    J Urol; 2001 Apr; 165(4):1268-73. PubMed ID: 11257699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EFFECTS OF PARATHYROIDECTOMY AND KIDNEY TRANSPLANTATION ON RENAL OSTEODYSTROPHY.
    WILSON RE; BERNSTEIN DS; MURRAY JE; MOORE FD
    Am J Surg; 1965 Sep; 110():384-93. PubMed ID: 14337994
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone disease in uremia.
    Stanbury SW
    Am J Med; 1968 May; 44(5):714-24. PubMed ID: 4869103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.